Opioid Use Disorder

Dec 3, 2020
About two years ago, the Buprenorphine Team — or B team — was formed at Dell Seton Medical Center in Austin, Texas, in collaboration with Dell Medical School at the University of Texas at Austin. Our goal is to offer Food and Drug Administration (FDA)-approved medications for patients with opioid…
Nov 23, 2020
Hospital outpatient departments, critical access hospitals, rural health clinics and other eligible providers may apply through Jan. 3 to participate in the Value in Opioid Use Disorder Treatment demonstration.
Nov 10, 2020
The Drug Enforcement Administration published an interim final rule expanding access to medication-assisted treatment under the SUPPORT for Patients and Communities Act of 2018.
Feb 26, 2020
The Alliance for Addiction Payment Reform, whose members include the AHA, showcased its value-based payment model for addiction and recovery support services at a briefing for congressional lawmakers and staff.
Dec 5, 2019
The Congressional Academic Medicine Caucus and the Association of American Medical Colleges today sponsored a Capitol Hill briefing to highlight the urgent nationwide need for more physicians to treat substance use disorders.
Nov 21, 2019
The Centers for Medicare & Medicaid Services (CMS) Nov. 1 issued a final rule updating physician fee schedule (PFS) payments for calendar year (CY) 2020. The rule also includes several policies implementing year four of the quality payment program (QPP) created by the Medicare Access and CHIP…
Oct 23, 2019
In the AHA Stat Blog marking National Addiction Treatment Week, Raymond Waller, hospital administrator at Ascension Brighton Center for Recovery in Brighton, Mich., and 2020 chair of AHA’s Behavioral Health Council, urges readers to ask their members of Congress to cosponsor this AHA-supported…
Oct 15, 2019
The AHA and six other organizations comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas.
Sep 25, 2019
The AHA supports a number of proposed policy changes that ensure access to care, support public health efforts, improve quality and promote regulatory relief. Specifically, we strongly support CMS’s proposed reversal of its previously finalized policies for evaluation and management payments.
Aug 23, 2019
AHA's feedback on the Department of Health and Human Services’ Office of the Assistant Secretary for Planning and Evaluation’s request for information on ensuring patient access and effective drug enforcement regarding controlled substances.